{"id":"https://openalex.org/W4361908564","doi":"https://doi.org/10.1158/1078-0432.22448261.v1","title":"Supplementary Table 1 from Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor\u2013Positive, HER2-Negative Metastatic Breast Cancer","display_name":"Supplementary Table 1 from Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor\u2013Positive, HER2-Negative Metastatic Breast Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908564","doi":"https://doi.org/10.1158/1078-0432.22448261.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22448261.v1","doi":"https://doi.org/10.1158/1078-0432.22448261.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22448261.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Quantitative_ER_and_PgR_Assessment_as_Predictors_of_Benefit_from_Lapatinib_in_Postmenopausal_Women_with_Hormone_Receptor_Positive_HER2-Negative_Metastatic_Breast_Cancer/22448261/1/files/39899303.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Quantitative_ER_and_PgR_Assessment_as_Predictors_of_Benefit_from_Lapatinib_in_Postmenopausal_Women_with_Hormone_Receptor_Positive_HER2-Negative_Metastatic_Breast_Cancer/22448261/1/files/39899303.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073989429","display_name":"Richard S. Finn","orcid":"https://orcid.org/0000-0003-2494-2126","observed_orcids":["https://orcid.org/0000-0003-2494-2126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard S. Finn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058453547","display_name":"Michael F. Press","orcid":"https://orcid.org/0000-0003-3400-6614","observed_orcids":["https://orcid.org/0000-0003-3400-6614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael F. Press","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066999153","display_name":"Judy Dering","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judy Dering","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109404305","display_name":"Lisa O\u2019Rourke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa O'Rourke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028520144","display_name":"Allison M. Florance","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison Florance","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028688292","display_name":"Catherine Elizabeth Ellis","orcid":"https://orcid.org/0009-0008-7635-7846","observed_orcids":["https://orcid.org/0009-0008-7635-7846"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Ellis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070535554","display_name":"Anne\u2010Marie Martin","orcid":"https://orcid.org/0000-0001-6446-7791","observed_orcids":["https://orcid.org/0000-0001-6446-7791","https://orcid.org/0009-0005-6678-8835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-Marie Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031915637","display_name":"Stephen R.D. Johnston","orcid":"https://orcid.org/0000-0002-9072-2749","observed_orcids":["https://orcid.org/0000-0002-9072-2749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Johnston","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7074999809265137,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7074999809265137,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.2378000020980835,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.027799999341368675,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.8579999804496765},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.5580000281333923},{"id":"https://openalex.org/keywords/progesterone-receptor","display_name":"progesterone receptor","score":0.984000027179718},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.9850000143051147},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8410000205039978},{"id":"https://openalex.org/keywords/clinical-characteristics","display_name":"clinical features","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.9556647539138794},{"id":"https://openalex.org/C2910363380","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"HER2 negative","level":5,"score":0.8328112363815308},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.686523973941803},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6608297824859619},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6468484997749329},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6409668922424316},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6007950901985168},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.5955718159675598},{"id":"https://openalex.org/C3018603563","wikidata":"https://www.wikidata.org/wiki/Q177708","display_name":"Postmenopausal women","level":2,"score":0.5936722755432129},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.44478780031204224},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.4356447756290436},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.42643821239471436},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3757435977458954},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.1293204426765442},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.09503880143165588},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22448261.v1","doi":"https://doi.org/10.1158/1078-0432.22448261.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22448261.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Quantitative_ER_and_PgR_Assessment_as_Predictors_of_Benefit_from_Lapatinib_in_Postmenopausal_Women_with_Hormone_Receptor_Positive_HER2-Negative_Metastatic_Breast_Cancer/22448261/1/files/39899303.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22448261","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Quantitative_ER_and_PgR_Assessment_as_Predictors_of_Benefit_from_Lapatinib_in_Postmenopausal_Women_with_Hormone_Receptor_Positive_HER2-Negative_Metastatic_Breast_Cancer/22448261","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22448261.v1","doi":"https://doi.org/10.1158/1078-0432.22448261.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22448261.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Quantitative_ER_and_PgR_Assessment_as_Predictors_of_Benefit_from_Lapatinib_in_Postmenopausal_Women_with_Hormone_Receptor_Positive_HER2-Negative_Metastatic_Breast_Cancer/22448261/1/files/39899303.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Gender equality","score":0.41999998688697815,"id":"https://metadata.un.org/sdg/5"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361908564.pdf","grobid_xml":"https://content.openalex.org/works/W4361908564.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2148105927","https://openalex.org/W4361944530","https://openalex.org/W4361882172","https://openalex.org/W2170292198","https://openalex.org/W4416626046","https://openalex.org/W2088573877","https://openalex.org/W6939691103","https://openalex.org/W2354847033","https://openalex.org/W2323780380","https://openalex.org/W2330947991"],"abstract_inverted_index":{"PDF":[0],"-":[1],"66K,":[2],"This":[3],"table":[4],"contains":[5],"the":[6,13],"clinical":[7],"characterisitcs":[8],"of":[9],"patients":[10],"enrolled":[11],"in":[12],"EGF":[14],"30008":[15],"trial.":[16]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-05T00:00:00"}